Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics
|
September 2, 1998
Catechol is the major product of salicylate hydroxylation in 1-methyl-4-phenylpyridinium ion treated rats
E Sam, S Sarre, Y Michotte, et al.
International Journal of Pharmaceutics
|
August 1, 2000
Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems
M Ikechukwu Ugwoke, G Kaufmann, N Verbeke, et al.
Pharmacy World & Science : PWS
|
April 23, 1993
Diminished sedation during diazepam treatment for chloroquine intoxication
K Croes, P Augustijns, M Sabbe, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
January 1, 1995
Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application
E Sam, A P Jeanjean, J M Maloteaux, et al.
Bollettino Chimico Farmaceutico
|
March 26, 2004
Intravenous versus subcutaneous injections of apomorphine in rabbits: a pharmacokinetic paradox
M I Ugwoke, R U Agu, R Kinget, et al.
Respiratory Research
|
November 1, 2001
The lung as a route for systemic delivery of therapeutic proteins and peptides
R U Agu, M I Ugwoke, M Armand, et al.
The Journal of Pharmacy and Pharmacology
|
December 6, 2001
In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies
R U Agu, M Jorissen, T Willems, et al.
International Journal of Pharmaceutics
|
June 17, 1999
Nasal mucoadhesive delivery systems of the anti-parkinsonian drug, apomorphine: influence of drug-loading on in vitro and in vivo release in rabbits
M Ikechukwu Ugwoke, E Sam, G Van Den Mooter, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 6, 2000
Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits
M I Ugwoke, S Exaud, G Van Den Mooter, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 9, 2000
Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa
M I Ugwoke, R U Agu, M Jorissen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
European Journal of Drug Metabolism and Pharmacokinetics
|
September 2, 1998
Catechol is the major product of salicylate hydroxylation in 1-methyl-4-phenylpyridinium ion treated rats
E Sam, S Sarre, Y Michotte, et al.
International Journal of Pharmaceutics
|
August 1, 2000
Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems
M Ikechukwu Ugwoke, G Kaufmann, N Verbeke, et al.
Pharmacy World & Science : PWS
|
April 23, 1993
Diminished sedation during diazepam treatment for chloroquine intoxication
K Croes, P Augustijns, M Sabbe, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
January 1, 1995
Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application
E Sam, A P Jeanjean, J M Maloteaux, et al.
Bollettino Chimico Farmaceutico
|
March 26, 2004
Intravenous versus subcutaneous injections of apomorphine in rabbits: a pharmacokinetic paradox
M I Ugwoke, R U Agu, R Kinget, et al.
Respiratory Research
|
November 1, 2001
The lung as a route for systemic delivery of therapeutic proteins and peptides
R U Agu, M I Ugwoke, M Armand, et al.
The Journal of Pharmacy and Pharmacology
|
December 6, 2001
In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies
R U Agu, M Jorissen, T Willems, et al.
International Journal of Pharmaceutics
|
June 17, 1999
Nasal mucoadhesive delivery systems of the anti-parkinsonian drug, apomorphine: influence of drug-loading on in vitro and in vivo release in rabbits
M Ikechukwu Ugwoke, E Sam, G Van Den Mooter, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 6, 2000
Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits
M I Ugwoke, S Exaud, G Van Den Mooter, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 9, 2000
Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa
M I Ugwoke, R U Agu, M Jorissen, et al.
Page
of 4